Clinical trial
Analysis of Disease Progression for Aplastic Anemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia and Benzene Poisoning in Shanghai, China.
NCT00365014 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Analysis of Disease Progression for Aplastic Anemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia and Benzene Poisoning in Shanghai, China.
- Lead sponsor
- University of Colorado, Denver
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 31, 2003
- Completion date
- December 31, 2009
- Enrollment
- 10,757 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.